FDA-approved epilepsy drug may help reverse osteoarthritis damage
FROM THE PUBLISHER
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
Original reporting by ScienceDaily. Some articles may require a subscription.